Report Detail
Global (United States, European Union and China) DTaP and Tdap Vaccines Market Research Report 2019-2025
- RnM3647726 |
- 06 August, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free environment. The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) recommend all children should be routinely vaccinated for pertussis. According to WHO in 2015, about 86% of infants received three doses of diphtheria-tetanus-pertussis (DTP3) vaccine worldwide to protect them against infectious diseases. In 2015, procurement of DTwP vaccine through UNICEF had reached 5.8 million doses for 18 countries and territories out of which four countries such as Egypt, Morocco, Uzbekistan, and Zimbabwe accounted for more than 80% of UNICEF’s total procurement.
Factors such as high birth rate, increase in number of geriatric population, government initiatives, growth in adoption of pertussis vaccination, and government insurance and reimbursement scenario are projected to drive the pertussis vaccine market globally. According to WHO in 2015, 126 countries had reached at least 90% coverage of diphtheria-tetanus-pertussis vaccine. On the other hand, factors such as vaccine injuries and adverse event are expected to hinder the growth of the pertussis vaccine market globally. In the U.S. in 2015, there had been 7 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following pertussis vaccination, including three deaths and four serious injuries.
The pertussis vaccine market has been segmented by product type, vaccine type, age group, end-user, and geography. In terms of product type, the pertussis vaccine market is classified into DTaP vaccine and Tdap vaccine. The DTaP vaccine segment includes products such as Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel. The Tdap vaccine segment comprises products such as Boostrix and Adacel. In terms of vaccine type, the pertussis vaccine market is classified into whole-cell vaccine and acellular vaccine. The acellular vaccine segment is highly used owing to less side effect. The acellular vaccine is about 71%–85% effective, whereas whole-cell vaccine is about 78% effective. In terms of age group, the pertussis vaccine market is classified into adult and pediatric. In terms of end-user, the market is classified into hospitals, clinics, and vaccination centers. Geographically, the pertussis vaccine market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America dominates the pertussis vaccine market due to growth in number of geriatric population and increase in pertussis death rate in the U.S, which drive the pertussis vaccine market. In 2014, according to the CDC, 28,660 cases of pertussis were reported in the U.S. The North America market is followed by the Europe and Asia Pacific markets. Asia Pacific is expected to grow at a higher rate due to rapid population growth, increase in adoption for vaccination, and growth in prevalence of infectious disease. These factors are expected to fuel the pertussis vaccine market. In the Asia Pacific region, Thailand accounts for 99% in pertussis vaccine coverage, followed by Japan and China with 98% and 97%, respectively. Developing countries such as Brazil, South Africa, and Mexico are estimated to create good opportunity for the pertussis vaccine market growth attributing to rise in number of government and private health care insurance coverage, increase in health care expenditure, and growth in awareness among people.
In 2019, the market size of DTaP and Tdap Vaccines is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for DTaP and Tdap Vaccines.
This report studies the global market size of DTaP and Tdap Vaccines, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the DTaP and Tdap Vaccines sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc
Market Segment by Product Type
DTaP
Td
Tdap
Market Segment by Application
Adult
Pediatric
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the DTaP and Tdap Vaccines status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key DTaP and Tdap Vaccines manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of DTaP and Tdap Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global DTaP and Tdap Vaccines Market Size Growth Rate by Type (2019-2025)
- 1.3.2 DTaP
- 1.3.3 Td
- 1.3.4 Tdap
- 1.4 Market Segment by Application
- 1.4.1 Global DTaP and Tdap Vaccines Market Share by Application (2019-2025)
- 1.4.2 Adult
- 1.4.3 Pediatric
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global DTaP and Tdap Vaccines Market Size
- 2.1.1 Global DTaP and Tdap Vaccines Revenue 2014-2025
- 2.1.2 Global DTaP and Tdap Vaccines Sales 2014-2025
- 2.2 DTaP and Tdap Vaccines Growth Rate by Regions
- 2.2.1 Global DTaP and Tdap Vaccines Sales by Regions 2014-2019
- 2.2.2 Global DTaP and Tdap Vaccines Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 DTaP and Tdap Vaccines Sales by Manufacturers
- 3.1.1 DTaP and Tdap Vaccines Sales by Manufacturers 2014-2019
- 3.1.2 DTaP and Tdap Vaccines Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 DTaP and Tdap Vaccines Revenue by Manufacturers (2014-2019)
- 3.2.2 DTaP and Tdap Vaccines Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global DTaP and Tdap Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.3 DTaP and Tdap Vaccines Price by Manufacturers
- 3.4 Key Manufacturers DTaP and Tdap Vaccines Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into DTaP and Tdap Vaccines Market
- 3.6 Key Manufacturers DTaP and Tdap Vaccines Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 DTaP Sales and Revenue (2014-2019)
- 4.1.2 Td Sales and Revenue (2014-2019)
- 4.1.3 Tdap Sales and Revenue (2014-2019)
- 4.2 Global DTaP and Tdap Vaccines Sales Market Share by Type
- 4.3 Global DTaP and Tdap Vaccines Revenue Market Share by Type
- 4.4 DTaP and Tdap Vaccines Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global DTaP and Tdap Vaccines Sales by Application
6 United States
- 6.1 United States DTaP and Tdap Vaccines Breakdown Data by Company
- 6.2 United States DTaP and Tdap Vaccines Breakdown Data by Type
- 6.3 United States DTaP and Tdap Vaccines Breakdown Data by Application
7 European Union
- 7.1 European Union DTaP and Tdap Vaccines Breakdown Data by Company
- 7.2 European Union DTaP and Tdap Vaccines Breakdown Data by Type
- 7.3 European Union DTaP and Tdap Vaccines Breakdown Data by Application
8 China
- 8.1 China DTaP and Tdap Vaccines Breakdown Data by Company
- 8.2 China DTaP and Tdap Vaccines Breakdown Data by Type
- 8.3 China DTaP and Tdap Vaccines Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World DTaP and Tdap Vaccines Breakdown Data by Company
- 9.2 Rest of World DTaP and Tdap Vaccines Breakdown Data by Type
- 9.3 Rest of World DTaP and Tdap Vaccines Breakdown Data by Application
- 9.4 Rest of World DTaP and Tdap Vaccines Breakdown Data by Countries
- 9.4.1 Rest of World DTaP and Tdap Vaccines Sales by Countries
- 9.4.2 Rest of World DTaP and Tdap Vaccines Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Sanofi Pasteur
- 10.1.1 Sanofi Pasteur Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of DTaP and Tdap Vaccines
- 10.1.4 DTaP and Tdap Vaccines Product Introduction
- 10.1.5 Sanofi Pasteur Recent Development
- 10.2 GlaxoSmithKline
- 10.2.1 GlaxoSmithKline Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of DTaP and Tdap Vaccines
- 10.2.4 DTaP and Tdap Vaccines Product Introduction
- 10.2.5 GlaxoSmithKline Recent Development
- 10.3 Protein Sciences Corporation
- 10.3.1 Protein Sciences Corporation Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of DTaP and Tdap Vaccines
- 10.3.4 DTaP and Tdap Vaccines Product Introduction
- 10.3.5 Protein Sciences Corporation Recent Development
- 10.4 Novartis AG
- 10.4.1 Novartis AG Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of DTaP and Tdap Vaccines
- 10.4.4 DTaP and Tdap Vaccines Product Introduction
- 10.4.5 Novartis AG Recent Development
- 10.5 Seqirus
- 10.5.1 Seqirus Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of DTaP and Tdap Vaccines
- 10.5.4 DTaP and Tdap Vaccines Product Introduction
- 10.5.5 Seqirus Recent Development
- 10.6 Merck Sharp & Dohme Corp
- 10.6.1 Merck Sharp & Dohme Corp Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of DTaP and Tdap Vaccines
- 10.6.4 DTaP and Tdap Vaccines Product Introduction
- 10.6.5 Merck Sharp & Dohme Corp Recent Development
- 10.7 Astellas Pharma US, Inc
- 10.7.1 Astellas Pharma US, Inc Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of DTaP and Tdap Vaccines
- 10.7.4 DTaP and Tdap Vaccines Product Introduction
- 10.7.5 Astellas Pharma US, Inc Recent Development
- 10.8 Pfizer Inc
- 10.8.1 Pfizer Inc Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of DTaP and Tdap Vaccines
- 10.8.4 DTaP and Tdap Vaccines Product Introduction
- 10.8.5 Pfizer Inc Recent Development
- 10.9 Johnson & Johnson
- 10.9.1 Johnson & Johnson Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of DTaP and Tdap Vaccines
- 10.9.4 DTaP and Tdap Vaccines Product Introduction
- 10.9.5 Johnson & Johnson Recent Development
- 10.10 Lanzhou Institute of Biological Products Co., Ltd
- 10.10.1 Lanzhou Institute of Biological Products Co., Ltd Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of DTaP and Tdap Vaccines
- 10.10.4 DTaP and Tdap Vaccines Product Introduction
- 10.10.5 Lanzhou Institute of Biological Products Co., Ltd Recent Development
- 10.11 AstraZeneca
- 10.12 Emergent BioSolutions Inc
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 DTaP and Tdap Vaccines Sales Channels
- 11.2.2 DTaP and Tdap Vaccines Distributors
- 11.3 DTaP and Tdap Vaccines Customers
12 Market Forecast
- 12.1 Global DTaP and Tdap Vaccines Sales and Revenue Forecast 2019-2025
- 12.2 Global DTaP and Tdap Vaccines Sales Forecast by Type
- 12.3 Global DTaP and Tdap Vaccines Sales Forecast by Application
- 12.4 DTaP and Tdap Vaccines Forecast by Regions
- 12.4.1 Global DTaP and Tdap Vaccines Sales Forecast by Regions 2019-2025
- 12.4.2 Global DTaP and Tdap Vaccines Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on DTaP and Tdap Vaccines. Industry analysis & Market Report on DTaP and Tdap Vaccines is a syndicated market report, published as Global (United States, European Union and China) DTaP and Tdap Vaccines Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of DTaP and Tdap Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
